Europe approves a Covid-19 crystal ball
Memed claims that its newly CE-marked test can predict Covid-19 severity.
Medtech venture funding hits new heights
Private device makers enjoy the biggest quarter for four years – and the average deal is larger than ever.
Guardant steps into a new arena
A test that tracks response to therapy is useful, but approval and reimbursement will be key.
